Descriptive Epidemiology of Travel and Non-Travel Related SARS-CoV-2 Gamma (P.1/501Y.V3) Variant Cases in England, 2021

IF 4.3 4区 医学 Q1 INFECTIOUS DISEASES
Nurin Abdul Aziz, Katherine Twohig, Mary Sinnathamby, Asad Zaidi, Shirin Aliabadi, Natalie Groves, Sophie Nash, Simon Thelwall, Gavin Dabrera
{"title":"Descriptive Epidemiology of Travel and Non-Travel Related SARS-CoV-2 Gamma (P.1/501Y.V3) Variant Cases in England, 2021","authors":"Nurin Abdul Aziz,&nbsp;Katherine Twohig,&nbsp;Mary Sinnathamby,&nbsp;Asad Zaidi,&nbsp;Shirin Aliabadi,&nbsp;Natalie Groves,&nbsp;Sophie Nash,&nbsp;Simon Thelwall,&nbsp;Gavin Dabrera","doi":"10.1111/irv.13308","DOIUrl":null,"url":null,"abstract":"<p>The Gamma (P.1/501Y.V3) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected through whole-genome sequencing (WGS) in Japan in early January 2021 among a group of travellers arriving from Brazil [<span>1</span>]. This was later reported in more than 50 countries, including England.</p><p>Early evidence from Brazil suggested that Gamma was associated with higher transmissibility and propensity for re-infection [<span>2</span>] as well as a possible increased likelihood of hospitalisation [<span>3</span>]. Considering the potential increased risks, further investigation into the epidemiology of the variant in other settings was necessary. Herein, we describe the epidemiology of the Gamma variant in England to 31 August 2021.</p><p>Individuals infected with the Gamma variant were identified through genotyping by polymerase chain reaction (PCR) and WGS from the national COVID-19 Genomics UK Consortium (COG-UK) sequencing initiative. These data were linked to demographic information held in UK Health Security Agency's Second Generation Surveillance System (SGSS) [<span>4</span>].</p><p>Travel exposure was derived from Passenger Location Forms (PLFs), required for entry to the United Kingdom, and routine NHS Test and Trace (T&amp;T) surveys. For cases with no known travel from these sources, information came from additional follow up by UKHSA's Health Protection Teams (HPTs).</p><p>Imported cases were defined as confirmed Gamma cases with international travel into England within 14 days before the earlier of symptom onset or specimen date. Secondary cases were those who had contact with a PCR-confirmed SARS-CoV-2 case who had travelled within 14 days of symptom onset or specimen date. Sporadic Gamma cases had no history of travel nor contact with a SARS-CoV-2 infected traveller. Only T&amp;T and HPT surveys could confirm secondary and sporadic cases. Cases without confirmation of travel status were excluded from the analysis.</p><p>Descriptive analysis was stratified by travel exposure, with imported and secondary cases grouped as travel-related, and examined by demographic factors including, age, sex, region and place of residence. Residence at the time of testing was identified by test location information or unique property registration number (UPRN); the latter was also used to derive data on residential clustering to assess potential onwards transmission based on initial travel status [<span>5</span>].</p><p>Between May and October 2021, the United Kingdom assigned Red, Amber and Green (RAG) categories to countries with perceived risk for importation of SARS-CoV-2 variants. Returning travellers from Red-listed countries required hotel quarantine in Managed Quarantine Facilities (MQF) and those returning from Amber-listed countries had at-home quarantine. In this analysis, travel-related cases were assigned a RAG category based on the highest rating of the countries involved in their journey at the time of travel [<span>6</span>]. Where RAG assignments were unavailable, an assignment of Red was given to those who travelled from a country on the initial travel ban list of countries associated with the Gamma variant [<span>7</span>].</p><p>Between 12 February and 31 August 2021, there were 251 confirmed Gamma cases detected in England. Excluding cases with no confirmation of travel status (<i>n</i> = 75, 29.9%), 88 (35.1%) were imported, 14 (5.6%) were secondary travel cases, and 74 (29.5%) were sporadic. Early Gamma cases were mostly imported or secondary cases (Figure 1). There were no reported deaths among confirmed Gamma cases in England during the study period.</p><p>Those aged between 20 and 29 years had the highest number of travel-related (<i>n</i> = 33, 32.4%) and sporadic cases (<i>n</i> = 19, 25.7%). Approximately half of both travel-related and sporadic cases were from the London region (Table S1).</p><p>Contrary to the expected areas of highest risk for importation, the majority of travel-related cases were associated with Amber countries as the highest RAG rating for their journeys (<i>n</i> = 52, 51.0%) (Table S1). However, 40.2% (<i>n</i> = 41) of travellers had visited Red countries, including the most frequently reported country of travel, Brazil (<i>n</i> = 27, 21.4%), which had been on the Red list since May 2021. Mexico, an Amber country upgraded to Red on 8 August 2021, had 15 returning travellers (11.9%), followed by Amber countries USA (<i>n</i> = 14, 11.9%) and France (<i>n</i> = 12, 11.1%). These travel-related cases include those detected within MQFs as part of the travel restrictions.</p><p>A larger proportion of sporadic cases were part of a residential cluster (<i>n</i> = 31, 41.9%) compared to travel-related cases (<i>n</i> = 28, 27.5%). Cluster size that included sporadic cases ranged from 2 to 6.</p><p>This analysis shows that earlier cases of the Gamma variant in England were predominantly travel-associated, transitioning to a larger proportion of cases likely obtained through community transmission. However, Gamma did not have widespread expansion, despite initial concerns of increased virulence and transmissibility. This may be due to the rapid dominance of Delta, which was observed to have surpassed Gamma in other parts of the world where the two variants co-occurred in greater numbers, such as Brazil and Mexico [<span>8, 9</span>]. At its peak, Gamma comprised of 2.8% of all cases in England with a variant designation, whereas in the same time period Delta was at 80.4% (Figure S1).</p><p>However, the proportion of travel-associated compared with sporadic cases may have been biased by targeted sequencing of new arrivals and their contacts as well as routine testing of travellers at the time of study [<span>10</span>]. Community-transmitted cases have potentially lower ascertainment, as they are subject to randomised population-level sample-picking processes. However, during the peak of Gamma incidence between March and June, the proportion of positive tests that were sequenced was above 50%, which should mitigate some of the risk for lower detection.</p><p>In October 2021, the RAG policy removed Amber and Green categories and only required quarantine for travellers from Red-list countries [<span>6</span>]. The analysis indicates the policy requiring quarantine in MQFs for Red-list travellers and at-home quarantine for Amber-list travellers, implemented from 7 May 2021, may have contributed to preventing onward transmission as suggested by the small numbers of secondary cases from the time of the policy being introduced. However, within the limitations of the available data, we are unable to definitively conclude which factors most contributed to the decline of Gamma detections in England. Further research is needed to explore the association between quarantine policies and secondary transmission of SARS-CoV-2 in other settings.</p><p>While larger scale surveillance of travellers has ceased, a similar approach could also be considered when new variants emerge, including using existing surveillance systems such as surveys to monitor the travel status of variant cases.</p><p><b>Nurin Abdul Aziz:</b> conceptualization, formal analysis, methodology, writing–original draft, writing–review and editing. <b>Katherine Twohig:</b> data curation, methodology, writing–original draft, writing–review and editing. <b>Mary Sinnathamby:</b> methodology, writing–original draft, writing–review and editing. <b>Asad Zaidi:</b> data curation, methodology, writing–original draft, writing–review and editing. <b>Shirin Aliabadi:</b> data curation, methodology, writing–review and editing. <b>Natalie Groves:</b> data curation, formal analysis, methodology, resources, software, writing–review and editing. <b>Sophie Nash:</b> methodology, writing–original draft, writing–review and editing. <b>Simon Thelwall:</b> methodology, supervision, writing–original draft, writing–review and editing. <b>Gavin Dabrera:</b> conceptualization, methodology, supervision, writing–review and editing.</p><p>The author declares no conflicts of interest.</p>","PeriodicalId":13544,"journal":{"name":"Influenza and Other Respiratory Viruses","volume":null,"pages":null},"PeriodicalIF":4.3000,"publicationDate":"2024-05-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/irv.13308","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Influenza and Other Respiratory Viruses","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/irv.13308","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0

Abstract

The Gamma (P.1/501Y.V3) variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) was first detected through whole-genome sequencing (WGS) in Japan in early January 2021 among a group of travellers arriving from Brazil [1]. This was later reported in more than 50 countries, including England.

Early evidence from Brazil suggested that Gamma was associated with higher transmissibility and propensity for re-infection [2] as well as a possible increased likelihood of hospitalisation [3]. Considering the potential increased risks, further investigation into the epidemiology of the variant in other settings was necessary. Herein, we describe the epidemiology of the Gamma variant in England to 31 August 2021.

Individuals infected with the Gamma variant were identified through genotyping by polymerase chain reaction (PCR) and WGS from the national COVID-19 Genomics UK Consortium (COG-UK) sequencing initiative. These data were linked to demographic information held in UK Health Security Agency's Second Generation Surveillance System (SGSS) [4].

Travel exposure was derived from Passenger Location Forms (PLFs), required for entry to the United Kingdom, and routine NHS Test and Trace (T&T) surveys. For cases with no known travel from these sources, information came from additional follow up by UKHSA's Health Protection Teams (HPTs).

Imported cases were defined as confirmed Gamma cases with international travel into England within 14 days before the earlier of symptom onset or specimen date. Secondary cases were those who had contact with a PCR-confirmed SARS-CoV-2 case who had travelled within 14 days of symptom onset or specimen date. Sporadic Gamma cases had no history of travel nor contact with a SARS-CoV-2 infected traveller. Only T&T and HPT surveys could confirm secondary and sporadic cases. Cases without confirmation of travel status were excluded from the analysis.

Descriptive analysis was stratified by travel exposure, with imported and secondary cases grouped as travel-related, and examined by demographic factors including, age, sex, region and place of residence. Residence at the time of testing was identified by test location information or unique property registration number (UPRN); the latter was also used to derive data on residential clustering to assess potential onwards transmission based on initial travel status [5].

Between May and October 2021, the United Kingdom assigned Red, Amber and Green (RAG) categories to countries with perceived risk for importation of SARS-CoV-2 variants. Returning travellers from Red-listed countries required hotel quarantine in Managed Quarantine Facilities (MQF) and those returning from Amber-listed countries had at-home quarantine. In this analysis, travel-related cases were assigned a RAG category based on the highest rating of the countries involved in their journey at the time of travel [6]. Where RAG assignments were unavailable, an assignment of Red was given to those who travelled from a country on the initial travel ban list of countries associated with the Gamma variant [7].

Between 12 February and 31 August 2021, there were 251 confirmed Gamma cases detected in England. Excluding cases with no confirmation of travel status (n = 75, 29.9%), 88 (35.1%) were imported, 14 (5.6%) were secondary travel cases, and 74 (29.5%) were sporadic. Early Gamma cases were mostly imported or secondary cases (Figure 1). There were no reported deaths among confirmed Gamma cases in England during the study period.

Those aged between 20 and 29 years had the highest number of travel-related (n = 33, 32.4%) and sporadic cases (n = 19, 25.7%). Approximately half of both travel-related and sporadic cases were from the London region (Table S1).

Contrary to the expected areas of highest risk for importation, the majority of travel-related cases were associated with Amber countries as the highest RAG rating for their journeys (n = 52, 51.0%) (Table S1). However, 40.2% (n = 41) of travellers had visited Red countries, including the most frequently reported country of travel, Brazil (n = 27, 21.4%), which had been on the Red list since May 2021. Mexico, an Amber country upgraded to Red on 8 August 2021, had 15 returning travellers (11.9%), followed by Amber countries USA (n = 14, 11.9%) and France (n = 12, 11.1%). These travel-related cases include those detected within MQFs as part of the travel restrictions.

A larger proportion of sporadic cases were part of a residential cluster (n = 31, 41.9%) compared to travel-related cases (n = 28, 27.5%). Cluster size that included sporadic cases ranged from 2 to 6.

This analysis shows that earlier cases of the Gamma variant in England were predominantly travel-associated, transitioning to a larger proportion of cases likely obtained through community transmission. However, Gamma did not have widespread expansion, despite initial concerns of increased virulence and transmissibility. This may be due to the rapid dominance of Delta, which was observed to have surpassed Gamma in other parts of the world where the two variants co-occurred in greater numbers, such as Brazil and Mexico [8, 9]. At its peak, Gamma comprised of 2.8% of all cases in England with a variant designation, whereas in the same time period Delta was at 80.4% (Figure S1).

However, the proportion of travel-associated compared with sporadic cases may have been biased by targeted sequencing of new arrivals and their contacts as well as routine testing of travellers at the time of study [10]. Community-transmitted cases have potentially lower ascertainment, as they are subject to randomised population-level sample-picking processes. However, during the peak of Gamma incidence between March and June, the proportion of positive tests that were sequenced was above 50%, which should mitigate some of the risk for lower detection.

In October 2021, the RAG policy removed Amber and Green categories and only required quarantine for travellers from Red-list countries [6]. The analysis indicates the policy requiring quarantine in MQFs for Red-list travellers and at-home quarantine for Amber-list travellers, implemented from 7 May 2021, may have contributed to preventing onward transmission as suggested by the small numbers of secondary cases from the time of the policy being introduced. However, within the limitations of the available data, we are unable to definitively conclude which factors most contributed to the decline of Gamma detections in England. Further research is needed to explore the association between quarantine policies and secondary transmission of SARS-CoV-2 in other settings.

While larger scale surveillance of travellers has ceased, a similar approach could also be considered when new variants emerge, including using existing surveillance systems such as surveys to monitor the travel status of variant cases.

Nurin Abdul Aziz: conceptualization, formal analysis, methodology, writing–original draft, writing–review and editing. Katherine Twohig: data curation, methodology, writing–original draft, writing–review and editing. Mary Sinnathamby: methodology, writing–original draft, writing–review and editing. Asad Zaidi: data curation, methodology, writing–original draft, writing–review and editing. Shirin Aliabadi: data curation, methodology, writing–review and editing. Natalie Groves: data curation, formal analysis, methodology, resources, software, writing–review and editing. Sophie Nash: methodology, writing–original draft, writing–review and editing. Simon Thelwall: methodology, supervision, writing–original draft, writing–review and editing. Gavin Dabrera: conceptualization, methodology, supervision, writing–review and editing.

The author declares no conflicts of interest.

Abstract Image

2021 年英格兰与旅行和非旅行相关的 SARS-CoV-2 伽马 (P.1/501Y.V3) 变异病例的描述性流行病学。
这可能是由于 Delta 型迅速占据主导地位,而在世界其他地区,如巴西和墨西哥,这两种变异型同时出现的数量较多,Delta 型已超过 Gamma 型[8,9]。然而,与散发性病例相比,旅行相关病例的比例可能因对新抵达者及其接触者进行有针对性的测序以及在研究期间对旅行者进行常规检测而有所偏差[10]。社区传播病例的确诊率可能较低,因为它们需要经过随机的人口抽样过程。然而,在 3 月至 6 月的伽马发病高峰期,测序阳性检测的比例超过了 50%,这在一定程度上降低了检出率较低的风险。2021 年 10 月,RAG 政策取消了黄色和绿色类别,只要求对来自红名单国家的旅行者进行检疫[6]。分析表明,从 2021 年 5 月 7 日开始实施的要求红名单旅行者在 MQFs 接受检疫和黄名单旅行者在家中接受检疫的政策,可能有助于防止病毒的继续传播,这一点从政策实施后出现的少量继发病例可以看出。然而,由于现有数据的局限性,我们无法明确断定哪些因素是导致英格兰伽马检测率下降的主要原因。虽然对旅行者的大规模监控已经停止,但当出现新的变异体时,也可以考虑采用类似的方法,包括利用现有的监控系统(如调查)来监控变异体病例的旅行状态。凯瑟琳-托希格(Katherine Twohig):数据整理、方法论、写作-原稿、写作-审阅和编辑。玛丽-辛纳坦比(Mary Sinnathamby):方法论、撰写-原稿、撰写-审阅和编辑。阿萨德-扎伊迪(Asad Zaidi):数据整理、方法论、撰写-原稿、撰写-审阅和编辑。Shirin Aliabadi:数据整理、方法论、写作-审稿和编辑。娜塔莉-格罗夫斯(Natalie Groves):数据整理、形式分析、方法论、资源、软件、撰写-审阅和编辑。索菲-纳什(Sophie Nash):方法论、写作-原稿、写作-审阅和编辑。Simon Thelwall:方法论、监督、撰写-原稿、撰写-审阅和编辑。加文-达布雷拉(Gavin Dabrera):构思、方法论、指导、撰写-初稿、撰写-审阅和编辑。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
CiteScore
7.20
自引率
4.50%
发文量
120
审稿时长
6-12 weeks
期刊介绍: Influenza and Other Respiratory Viruses is the official journal of the International Society of Influenza and Other Respiratory Virus Diseases - an independent scientific professional society - dedicated to promoting the prevention, detection, treatment, and control of influenza and other respiratory virus diseases. Influenza and Other Respiratory Viruses is an Open Access journal. Copyright on any research article published by Influenza and Other Respiratory Viruses is retained by the author(s). Authors grant Wiley a license to publish the article and identify itself as the original publisher. Authors also grant any third party the right to use the article freely as long as its integrity is maintained and its original authors, citation details and publisher are identified.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信